RSSCategory: Biotechnology

Social media is not to blame for depression in young people

Social media is not to blame for depression in young people

By Niall McCrae, Lecturer in Mental Health, King’s College London, London, UK For all we hear about an escalation in mental health problems in adolescence, there is no persuasive evidence that the internet is to blame. My colleagues and I recently conducted a systematic review of the evidence and found only a weak correlation between teenagers’ […]

March 2, 2017 | By | Reply More
Organoids – the future of medical research

Organoids – the future of medical research

Perspective By Louise Thompson, PhD candidate in Molecular and Cellular Physiology University of Liverpool, Liverpool, UK. Most of the research behind new medical advances is carried out using either animal tissues or cancer cells. Both tools have their problems: results from animals and humans do not always match up and cancer cells grown for years in […]

February 20, 2017 | By | Reply More
5 reasons why an $89,000 drug has Congress fuming

5 reasons why an $89,000 drug has Congress fuming

By Sarah Jane Tribble and Sydney Lupkin Kaiser Health News The latest flashpoint in the ongoing debate over high drug prices is Emflaza, an $89,000-a-year drug that treats Duchenne muscular dystrophy. People who have been watching the drug price issue closely, however, can reasonably ask why there is so much heat at that price tag? […]

February 16, 2017 | By | Reply More
Cool Videos: Starring the wiring diagram of the human brain

Cool Videos: Starring the wiring diagram of the human brain

By Dr. Francis Collins, Director of the National Institutes of Health See how tractography is helping scientists get a better picture of the human brain. The human brain contains distinct geographic regions that communicate throughout the day to process information, such as remembering a neighbor’s name or deciding which road to take to work. Key to […]

February 16, 2017 | By | Reply More
Stem cell transplant induces remission in multiple sclerosis

Stem cell transplant induces remission in multiple sclerosis

From the National Institutes of Health Immunosuppressive therapy followed by stem cell transplantation induced remission of a common form of multiple sclerosis over a 5-year follow-up period. Multiple sclerosis causes damage to the brain and nerve fibers. yodiyim/iStock/Thinkstock. MS is an autoimmune disease in which the immune system attacks the central nervous system. It results in […]

February 15, 2017 | By | Reply More
Influenza: The search for a universal vaccine

Influenza: The search for a universal vaccine

By Ian Setliff, Ph.D. Student, Program in Chemical & Physical Biology aand Amyn Murji, Ph.D. Student, Department of Microbiology and Immunology. Vanderbilt Vaccine Center, Vanderbilt University, Nashville, Tennessee No one wants to catch the flu, and the best line of defense is the seasonal influenza vaccine. But producing an effective annual flu shot relies on accurately predicting which […]

February 13, 2017 | By | Reply More
Dozens of new cancer drugs do little to improve survival

Dozens of new cancer drugs do little to improve survival

By Liz Szabo Kaiser Health News Marlene McCarthy’s breast cancer has grown relentlessly over the past seven years, spreading painfully through her bones and making it impossible to walk without a cane. Although the 73-year-old knows there’s no cure for her disease, she wants researchers to do better. It’s been years, she said, since she […]

February 10, 2017 | By | Reply More
Could a contraceptive app be as good as the pill?

Could a contraceptive app be as good as the pill?

By Susan Walker, Senior Research Fellow/ Senior Lecturer in Sexual Health Anglia Ruskin University, East Anglia, United Kingdom. There’s a company that claims its smartphone fertility-tracking app is as good as the pill at preventing pregnancy. Women have long monitored their menstrual cycles as a method of contraception but this has often been seen as unreliable because […]

February 7, 2017 | By | Reply More
Getting patients hooked on an opioid overdose antidote, then raising the price

Getting patients hooked on an opioid overdose antidote, then raising the price

By Shefali Luthra Kaiser Health News First came Martin Shkreli, the brash young pharmaceutical entrepreneur who raised the price for an AIDS treatment by 5,000 percent. Then, Heather Bresch, the CEO of Mylan, who oversaw the price hike for its signature Epi-Pen to more than $600 for a twin-pack, though its active ingredient costs pennies […]

January 30, 2017 | By | Reply More
The future of stem cells: tackling hype versus hope

The future of stem cells: tackling hype versus hope

By Melissa Little, Program Leader of Stem Cells Australia University of Melbourne, Melbourne, Australia For many people suffering from disabling conditions, such as Parkinson’s disease, spinal injury and paralysis, multiple sclerosis, macular degeneration, heart disease, renal failure and even cancer, announcements in the press around breakthroughs in stem cell research undoubtedly bring hope. The challenge remains how to […]

January 28, 2017 | By | Reply More